CAI FY 2025 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$812M+97.0% YoY

Gross Profit

$539M66.4% margin

Operating Income

$45M5.6% margin

Net Income

-$538M-66.2% margin

EPS (Diluted)

$-1.90

Cash Flow

Operating Cash Flow

$83M

Free Cash Flow

$67M

Stock-Based Comp.

$70M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$548M

Stockholders' Equity

$577M

Cash & Equivalents

$798M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$812M	$412M	+97.0%
Gross Profit	$539M	$179M	+201.6%
Operating Income	$45M	-$257M	+117.5%
Net Income	-$538M	-$282M	-90.8%